• / Free eNewsletters & Magazine
  • / My Account
Home>Companies>Eli Lilly

Eli Lilly

Eli Lilly and Co LLY

Last Price$74.99Day Change (%)-0.70%
Open Price$75.52Day Change ($)-0.53
Day Range74.66–75.7252-Week Range67.88–92.85

As of Fri 5/27/2016 6:07:00 PM | USD

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  1. Global Osteoarthritis Treatment Market Forecasts to 2022 - Key Players are Novartis AG, Pfizer & Eli Lilly and Company - Research and Markets

    Global Osteoarthritis Treatment Market Forecasts to 2022 - Key Players are Novartis AG, Pfizer & Eli Lilly and Company - Research and Markets

  2. Ulcerative Colitis - Pipeline Review, H1 2016 - Key Players Include Amgen, Gilead Sciences & Celgene Corporation - Research and Markets

    Ulcerative Colitis - Pipeline Review, H1 2016 - Key Players Include Amgen, Gilead Sciences & Celgene Corporation - Research and Markets

  3. Global Biliary Cirrhosis Clinical Trials Review, H1, 2016 - Analysis, Technologies & Forecasts Report - Key Vendors: Genextra, Shire, NovImmune - Research and Markets

    Global Biliary Cirrhosis Clinical Trials Review, H1, 2016 - Analysis, Technologies & Forecasts Report - Key Vendors: Genextra, Shire, NovImmune - Research and Markets

  4. UPDATE: Four reasons for investors to buy biotechnology stocks now

    UPDATE: Four reasons for investors to buy biotechnology stocks now

  5. Global Alzheimer's Therapeutic Market Forecasts to 2022 - Key Players are Acadia Pharmaceuticals, Biotie Therapies & Pfizer - Research and Markets

    Global Alzheimer's Therapeutic Market Forecasts to 2022 - Key Players are Acadia Pharmaceuticals, Biotie Therapies & Pfizer - Research and Markets

  6. Global Renal Cell Carcinoma Drugs Market Worth USD 4.3 Billion by 2021 - Analysis, Technologies & Forecasts Report 2016-2021 - Key Vendors: Acceleron, Bionomics, Eisai - Research and Markets

    Global Renal Cell Carcinoma Drugs Market Worth USD 4.3 Billion by 2021 - Analysis, Technologies & Forecasts Report 2016-2021 - Key Vendors: Acceleron, Bionomics, Eisai - Research and Markets

  7. Worldwide Metastatic Melanoma Pipeline Review 2016 - 50+ Companies & Drug Profiles - Research and Markets

    Worldwide Metastatic Melanoma Pipeline Review 2016 - 50+ Companies & Drug Profiles - Research and Markets

  8. Global Uveal Melanoma Pipeline Review, H1 2016 - Analysis, Technologies & Forecasts Report - Key Vendors: Aura Biosciences, Novartis, Pfizer - Research and Markets

    Global Uveal Melanoma Pipeline Review, H1 2016 - Analysis, Technologies & Forecasts Report - Key Vendors: Aura Biosciences, Novartis, Pfizer - Research and Markets

  9. Health Insurers Push to Tie Drug Prices to Outcomes

    Health Insurers Push to Tie Drug Prices to Outcomes

  10. Salesforce Adds 800 Jobs in Indiana After Civil Rights Win

    Salesforce Adds 800 Jobs in Indiana After Civil Rights Win

12345
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.